Company Filing History:
Years Active: 2003-2007
Title: Clif Alferness: Innovator in Cardiac Treatment Solutions
Introduction
Clif Alferness, an accomplished inventor based in Redmond, WA, has significantly contributed to the field of cardiac treatment. With a total of three patents to his name, he is recognized for his innovative approaches to addressing congestive heart disease through medical devices.
Latest Patents
Among his notable inventions is a patented device titled "Septum attached ventricular support." This method and device are designed for treating congestive heart disease by securing material to the heart proximate the septal wall. One of the key features of this device is that the material can cover the left and right ventricles with the possibility of different tension and compliance. The device can be configured as a unitary 'jacket' that fits over the apex of the heart or as multiple separate components. Additionally, it includes adjustment mechanisms to finely tune the tension for each ventricle independently.
Another significant patent from Clif Alferness is related to a "Cardiac disease treatment and device," which encompasses similar features as the Septum attached ventricular support, further emphasizing the versatility and adaptability of his innovation in addressing heart conditions.
Career Highlights
Clif Alferness is currently associated with Acorn Cardiovascular, Inc., a company focused on developing solutions for cardiovascular health. His career is marked by a commitment to advancing medical technology to improve patient outcomes in cardiac care.
Collaborations
Throughout his career, Alferness has collaborated with distinguished professionals in the field, including J Edward Shapland and Michael J Girard. These partnerships have facilitated a rich exchange of ideas and expertise, contributing to the advancement of innovative heart treatment solutions.
Conclusion
Clif Alferness stands out as a visionary inventor in the realm of cardiac treatments. His patents not only showcase his innovative spirit but also reflect his dedication to enhancing the quality of life for individuals affected by heart disease. With ongoing collaborations and a career rooted in innovation, Alferness continues to influence the landscape of medical technology.